Overview

Development of Vitamin D as a Therapy for Breast Cancer - Phase 2

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
This study will assess whether levels of vitamin D impact the characteristics of a woman's breast cancer at diagnosis, and whether a short course of vitamin D in women with low levels of vitamin D changes the gene expression of their breast cancers.
Phase:
Phase 2
Details
Lead Sponsor:
Stanford University
Collaborator:
United States Department of Defense
Treatments:
Calcipotriene
Ergocalciferols
Vitamin D
Vitamins